24 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
for sale or contract to sell) or otherwise commercially Exploit (including to conduct pricing and reimbursement activities) a pharmaceutical … and maintain the Regulatory Approvals and applicable pricing or reimbursement approvals.
1.20. “Field” shall mean all human diseases, symptoms
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
to which governmental authorities and health insurers establish coverage, adequate reimbursement levels and favorable pricing policies.
Risks … candidate is approved;
our ability to achieve sufficient market acceptance, coverage and adequate reimbursement from third-party payors and adequate
20-F
EX-4.11
whg98xlkb2x6skmh08
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
0tbbtcevx7uvw65
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
077ip2 2wa0j3u
31 Mar 22
Annual report (foreign)
4:33pm
S-8
EX-4.3
yss60tsxq3i cpv1kg
19 Mar 21
Registration of securities for employees
5:13pm
424B4
y4ig mluqw
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
mtumzmh2c39t4o
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
t70c71h2f51
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-1.1
obtr31crc7wmkc
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-4.2
9v4p6y1bqmeopwdoc98z
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-6
EX-4
gjznol cfzf8031r4
12 Mar 21
Registration for ADRs (foreign)
4:05pm
F-1
EX-10.15
be8k5
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.8
8vhvx8e7r5lq otwt
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.11
qr7n p849ul18
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.5
7osjbdubx7ubfviusc
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
wh0q1sko2q6dbz1l
26 Feb 21
Registration statement (foreign)
4:56pm